'Antibody testing' presentation slideshows

BLOOD BORNE PATHOGENS

568 views • 36 slides

MIOSHA Part 554 Bloodborne Infectious Diseases Train the Trainer Program Module 2

MIOSHA Part 554 Bloodborne Infectious Diseases Train the Trainer Program Module 2. Presented By: Consultation Education & Training (CET) Division Michigan Occupational Safety & Health Administration Michigan Department of Energy, Labor & Economic Growth www.michigan.gov/miosha

345 views • 34 slides

MIOSHA Part 554 Bloodborne Infectious Diseases Train the Trainer Program Module 2

MIOSHA Part 554 Bloodborne Infectious Diseases Train the Trainer Program Module 2. Presented By: Consultation Education & Training (CET) Division Michigan Occupational Safety & Health Administration www.michigan.gov/miosha (517) 284-7720. Welcome.

343 views • 34 slides

BLOODBORNE PATHOGENS

BLOODBORNE PATHOGENS. What Are Bloodborne Pathogens?. Bloodborne pathogens are microorganisms such as viruses or bacteria that are carried in blood and can cause disease in people. Bloodborne Diseases. HIV: Human Immunodeficiency Virus causes AIDS - no cure or vaccination

412 views • 25 slides

Antibody Testing

491 views • 20 slides

Module 4: Testing and monitoring

Module 4: Testing and monitoring. Module 5: Testing and monitoring. Module goal To introduce participants to best practice regarding the different tests, which are encountered in the diagnosis and management of HCV Learning objectives

393 views • 19 slides

Module 6 After the survey

Training in monitoring and epidemiological assessment of mass drug administration for eliminating lymphatic filariasis. Module 6 After the survey. Learning objectives. By the end of this module, you should understand the actions required after a TAS: Interpreting the result of the survey

542 views • 17 slides

Workshop Summary FDA Workshop on Testing for malarial Infections in Blood Donors

Workshop Summary FDA Workshop on Testing for malarial Infections in Blood Donors. Sanjai Kumar, Ph.D. Center for Biologics Evaluation and Research Food and Drug Administration Blood Products Advisory Committee Meeting July 13, 2006. Issue.

305 views • 17 slides